Monitoring clinical trials

New Zealand Medical Journal

Volumn 111, Issue 1072, 1998, Pages 322-325

  Sharples, Katrina ^a   Fleming, Thomas R ^b   MacMahon, Stephen ^c   Moore, Andrew ^d   Reid, Ian ^c   Scoggins, Bruce ^e  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d UNIVERSITY OF OTAGO   (New Zealand)

^e Hlth Res Council of New Zealand   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PROTOCOL; CLINICAL TRIAL; HEALTH CARE QUALITY; HUMAN; MEDICAL ETHICS; METHODOLOGY; NEW ZEALAND; PRACTICE GUIDELINE; REVIEW; STANDARD;

CLINICAL PROTOCOLS; CLINICAL TRIALS; ETHICS, MEDICAL; GUIDELINE ADHERENCE; GUIDELINES; HUMANS; NEW ZEALAND; PROGRAM EVALUATION; RESEARCH DESIGN;

EID: 0032575425     PISSN: 00288446     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Ministry of Health, Therapeutics Section. Interim New Zealand Guideline for Good Clinical Research Practice. Wellington: Ministry of Health; 1996.
2. CAST Investigators. Effect of encainide and flecainide on mortality in a randomised trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989; 312: 406-12.
3. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991; 338: 131-7.
4. O'Rourke PP, Crone RK, Vacanti JP et al. Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: a prospective randomised study. Pediatrics 1989; 84: 957-63.
5. Ware JH. Investigating therapies of potentially great benefit: ECMO. Stat Sci 1989; 4: 298-310.
6. Pocock SJ. When to stop a clinical trial. BMJ 1992; 305: 235-40.
7. Soll RF. Neonatal extracorporeal membrane oxygenation - a bridging technique. Lancet 1996; 348: 70-1.
8. UK Collaborative ECMO trial group. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. Lancet 1996; 348: 75-82.
9. ISIS-2 Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2 Lancet 1988; ii: 349-60.
10. Doll R. Development of controlled trials in preventive and therapeutic medicine. J Biosoc Sci 1991; 3: 365-78.
11. Fischl MA, Richman DD, Grieco MH et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial. N Engl J Med 1987; 317: 185-91.
12. Volberding PA, Lagakos SW, Koch MA et al. Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. N Engl J Med 1990; 322: 941-9.
13. Bartlett JG. Zidovudine now or later? N Engl J Med 1993; 329: 351-2.
14. Concorde Coordinating Committee. Concorde MRC/ANRS randomised double-blind controlled trial of immediate versus deferred zidovudine in symptom-free HIV infection. Lancet 1994; 343: 871-81.
15. Peto T, Darbyshire J. Lessons from the Concorde trial. Br J Hosp Med 1994; 52: 378-9
16. Emerson SS, Fleming TR. Parameter estimation following group sequential hypothesis testing. Biometrika 1990; 77: 875-92.
17. Coronary Drug Project Group. Practical aspects of decision making in clinical trials: The Coronary Drug Project as a case study. Control Clin Trials 1981; 1: 363-76.
18. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979; 35: 549-56.
19. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983; 70: 659-63.
20. Armitage P. Sequential Medical Trials 2nd ed. New York: John Wiley and Sons; 1975.
21. Freedman LS, Spiegelhalter DJ, Parmar MKB. The what, why and how of Bayesian clinical trials monitoring. Stat Med 1994; 13: 1371-83.
22. Green SJ, Fleming TR, O'Fallon JR. Policies for study monitoring and interim reporting of results. J Clin Oncol 1987; 5: 1477-84.